The Complexities of Intestinal Lipoprotein Production in Insulin Resistance and Diabetes: Revisiting a 2010 Diabetes Classic by Pavlic et al

Gary F Lewis,Erin E Mulvihill,Gary F. Lewis,Erin E. Mulvihill

DOI: https://doi.org/10.2337/dbi23-0036

IF: 7.7

2024-02-22

Diabetes

Abstract:Assembly and secretion of triglyceride-rich lipoproteins in the liver (very-low-density lipoproteins [VLDL]) and intestine (chylomicrons) are essential processes required for interorgan nutrient transport and whole-body energy metabolism. Over many decades, intensive research into the multifaceted regulation of hepatic VLDL assembly and secretion has contributed to a sophisticated understanding of the molecular mechanisms governing VLDL secretion (1). In contrast, there is increasing appreciation that intestinal lipoprotein assembly and secretion is not simply determined by fat ingestion (2) but is also regulated by the integration of signals from a multitude of systemic and paracrine factors (3,4). Furthermore, dysregulation of VLDL secretion in insulin-resistant states and diabetes has been well described for several decades, whereas dysregulation of chylomicron secretion in insulin resistance and diabetes has only more recently been appreciated (5,–,7). The observation that intestinal remnant lipoproteins, derived from the intravascular lipolysis of chylomicrons, are elevated in people living with insulin resistance and diabetes, along with speculation that these cholesterol-rich remnants contribute to atherogenesis, have stimulated further evaluation of the mechanisms that influence this process and have driven the study of intrinsic molecular dysregulation of intestinal lipoproteins (8,9).

endocrinology & metabolism